title: Rac guanosine triphosphatases represent a potential target in AML.
authors.forename: L U W
authors.initials: LU
authors.lastname: Müller
authors.forename: R J
authors.initials: RJ
authors.lastname: Schore
authors.forename: Y
authors.initials: Y
authors.lastname: Zheng
authors.forename: E K
authors.initials: EK
authors.lastname: Thomas
authors.forename: M-O
authors.initials: MO
authors.lastname: Kim
authors.forename: J A
authors.initials: JA
authors.lastname: Cancelas
authors.forename: Y
authors.initials: Y
authors.lastname: Gu
authors.forename: D A
authors.initials: DA
authors.lastname: Williams
mesh_terms: D000634:Aminoquinolines; D000818:Animals; D002453:Cell Cycle / Q000187:drug effects; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D016503:Drug Delivery Systems; D004354:Drug Screening Assays, Antitumor; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D051379:Mice; D011743:Pyrimidines; D015996:Survival Rate; D014183:Transplantation, Heterologous; D020744:rac GTP-Binding Proteins / Q000037:antagonists & inhibitors*
chemical_list: D000634:Aminoquinolines; D004791:Enzyme Inhibitors; C487513:NSC 23766; D011743:Pyrimidines; D020744:rac GTP-Binding Proteins